Animal study · mice

5-Amino-1MQ slowed bladder tumor growth in mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This is cancer research in mice that used 5-Amino-1MQ to block NNMT, and it tells you nothing about its effects or safety in people.

Kind
Animal study
Studied in
Mice
Published
2024
Journal
J Immunother Cancer

What they tested

The team wanted to know whether the enzyme NNMT in tumor support cells is tied to bladder cancer outcomes and immunotherapy response, and whether blocking it with 5-Amino-1MQ changes tumor growth.

How the study was done

A lab and animal study that combined bladder cancer tissue from two independent large patient groups with gene-editing experiments and mouse models of urothelial bladder cancer. In the mice, 5-Amino-1MQ was given alone and alongside an anti-PD-L1 antibody, a type of immunotherapy.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking 5-Amino-1MQ? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In mice with bladder tumors, 5-Amino-1MQ significantly reduced tumor growth and boosted the apoptosis (programmed cell death) effects of the anti-PD-L1 antibody. In patient samples, high NNMT in cancer-associated fibroblasts (support cells around the tumor) was significantly linked to not responding to PD-L1 blockade and to a worse outlook. The team found that these fibroblasts draw in immune cells called tumor-associated macrophages through a protein called serum amyloid A, which drove tumor cell growth and resistance to immunotherapy.

What it doesn’t show

5-Amino-1MQ was tested only in mice, so its effect on tumors is not a human result. The patient part looked at tumor tissue and links to outcomes, and no person received the compound.

The paper

Yang et al. NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024.

The compounds

More studies on 5-Amino-1MQ

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking 5-Amino-1MQ? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo